{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:20:12Z","timestamp":1783408812678,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004913","name":"Universit\u00e0 degli Studi di Palermo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004913","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Benign Essential Blepharospasm (BEB) is a focal dystonia that leads to an increased rate of eyelid closure due to involuntary activation of the orbicularis oculi muscles. In severe cases, daily activities can significantly be affected, with reduced quality of life. Injections of OnabotulinumtoxinA are often used as valid therapeutical option. However, this treatment may not be tolerated by all patients, considering its invasive nature and the need for access to specialized centers. Despite oral agents, such as benzodiazepines (particularly clonazepam), are often used as a first-line treatment, evidence regarding their efficacy remains fragmentary.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This scoping review aims to evaluate the current evidence for the efficacy of clonazepam for benign essential blepharospasm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Articles in English about the use of clonazepam in the treatment of BEB were searched for in three major databases (PubMed, Scopus, Cochrane).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The search yielded 259 results. After screening, 13 papers were sought for retrieval. After assessing their suitability, 2 articles were included in the review: one open-label trial and one case report. Despite some limitations, both showed the effectiveness of clonazepam in BEB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although some evidence supports the use of clonazepam in the treatment of BEB, high-quality studies are still needed to clarify aspects such as response rates, optimal dose, and other disease management issues. This information may be useful for clinicians who are unable to refer their patients to specialized centers and must rely on their own experience and anecdotal evidence for patient management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10072-026-09172-4","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T02:42:15Z","timestamp":1781491335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A scoping review about the efficacy of clonazepam for the treatment of benign essential blepharospasm"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0585-8351","authenticated-orcid":false,"given":"Angelo","family":"Torrente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3627-8974","authenticated-orcid":false,"given":"Paolo","family":"Alonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8883-5701","authenticated-orcid":false,"given":"Antonia","family":"Pignolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2418-3240","authenticated-orcid":false,"given":"Eloise","family":"Lo Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2829-523X","authenticated-orcid":false,"given":"Roberto","family":"Monastero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8827-7324","authenticated-orcid":false,"given":"Angelo","family":"Labate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"9172_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VSC, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK (2013) Phenomenology and classification of dystonia: A consensus update. Mov Disord 28:863\u2013873","journal-title":"Mov Disord"},{"key":"9172_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/01.iio.0000167238.26526.a8","volume":"45","author":"GJ Simon","year":"2005","unstructured":"Simon GJ, Ben, McCann JD (2005) Benign Essential Blepharospasm. Int Ophthalmol Clin 45:49\u201375. https:\/\/doi.org\/10.1097\/01.iio.0000167238.26526.a8","journal-title":"Int Ophthalmol Clin"},{"key":"9172_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/IIO.0000000000000207","volume":"58","author":"CJ Hwang","year":"2018","unstructured":"Hwang CJ, Eftekhari K (2018) Benign Essential Blepharospasm: What We Know and What We Don\u2019t. Int Ophthalmol Clin 58:11\u201324. https:\/\/doi.org\/10.1097\/IIO.0000000000000207","journal-title":"Int Ophthalmol Clin"},{"key":"9172_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/mds.25532","volume":"28","author":"A Quartarone","year":"2013","unstructured":"Quartarone A, Hallett M (2013) Emerging concepts in the physiological basis of dystonia. Mov Disord 28:958\u2013967","journal-title":"Mov Disord"},{"key":"9172_CR5","doi-asserted-by":"publisher","unstructured":"Dong H, Luo Y, Fan S, Yin B, Weng C, Peng B (2020) Screening gene mutations in Chinese patients with benign essential blepharospasm. Front Neurol 10. https:\/\/doi.org\/10.3389\/fneur.2019.01387","DOI":"10.3389\/fneur.2019.01387"},{"key":"9172_CR6","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/mds.25244","volume":"27","author":"TD Steeves","year":"2012","unstructured":"Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T (2012) The prevalence of primary dystonia: A systematic review and meta-analysis. Mov Disord 27:1789\u20131796. https:\/\/doi.org\/10.1002\/mds.25244","journal-title":"Mov Disord"},{"key":"9172_CR7","doi-asserted-by":"crossref","unstructured":"Defazio G, Livrea P (2004) Primary blepharospasm diagnosis and management","DOI":"10.2165\/00003495-200464030-00002"},{"key":"9172_CR8","doi-asserted-by":"crossref","unstructured":"Defazio G, Hallett M, Jinnah HA, Berardelli A (2013) Development and validation of. a clinical guideline for diagnosing blepharospasm","DOI":"10.1212\/WNL.0b013e31829bfdf6"},{"key":"9172_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.parkreldis.2021.09.004","volume":"91","author":"G Defazio","year":"2021","unstructured":"Defazio G, Jinnah HA, Berardelli A, Perlmutter JS, Berkmen GK, Berman BD, Jankovic J, B\u00e4umer T, Comella C, Cotton AC, Ercoli T, Ferrazzano G, Fox S, Kim HJ, Moukheiber ES, Richardson SP, Weissbach A, Wrigth LJ, Hallett M (2021) Diagnostic criteria for blepharospasm: A multicenter international study. Parkinsonism Relat Disord 91:109\u2013114. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.09.004","journal-title":"Parkinsonism Relat Disord"},{"key":"9172_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1001\/archopht.124.1.116","volume":"124","author":"TA Hall","year":"2006","unstructured":"Hall TA, McGwin G Jr, Searcey K, Xie A, Hupp SL, Owsley C, Kline LB (2006) Health-Related Quality of Life and Psychosocial Characteristics of Patients With Benign Essential Blepharospasm. Arch Ophthalmol 124:116\u2013119. https:\/\/doi.org\/10.1001\/archopht.124.1.116","journal-title":"Arch Ophthalmol"},{"key":"9172_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000310837","volume":"211","author":"SB \u00d6zkan","year":"2010","unstructured":"\u00d6zkan SB, Can D, S\u00f6ylev MF, Arsan AK, Duman S (2010) Chemodenervation in Treatment of Upper Eyelid Retraction. Ophthalmologica 211:387\u2013390. https:\/\/doi.org\/10.1159\/000310837","journal-title":"Ophthalmologica"},{"key":"9172_CR12","unstructured":"Duarte GS, Rodrigues FB, Marques RE, Castel\u00e3o M, Ferreira J, Sampaio C, Moore AP, Costa J (2020) Botulinum toxin type A therapy for blepharospasm. Cochrane Database of Systematic Reviews 2020"},{"key":"9172_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/01658107.2018.1542009","volume":"43","author":"F Vivancos-Matellano","year":"2019","unstructured":"Vivancos-Matellano F, Rodr\u00edguez-Sanz A, Herrero-Infante Y, Masc\u00edas-Cadavid J (2019) Efficacy and Safety of Long-Term Therapy with Type A Botulinum Toxin in Patients with Blepharospasm. Neuro-Ophthalmology 43:277\u2013283. https:\/\/doi.org\/10.1080\/01658107.2018.1542009","journal-title":"Neuro-Ophthalmology"},{"key":"9172_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00417-006-0392-5","volume":"245","author":"B Wabbels","year":"2007","unstructured":"Wabbels B, Roggenk\u00e4mper P (2007) Long-term follow-up of patients with frontalis sling operation in the treatment of essential blepharospasm unresponsive to botulinum toxin therapy. Graefe\u2019s Archive Clin Experimental Ophthalmol 245:45\u201350. https:\/\/doi.org\/10.1007\/s00417-006-0392-5","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol"},{"key":"9172_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00702-021-02339-7","volume":"128","author":"MAC Sy","year":"2021","unstructured":"Sy MAC, Fernandez HH (2021) Dystonia and leveraging oral pharmacotherapy. J Neural Transm 128:521\u2013529","journal-title":"J Neural Transm"},{"key":"9172_CR16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jocn.2020.03.025","volume":"75","author":"KA Woo","year":"2020","unstructured":"Woo KA, Kim HJ, Yoo D, Choi JH, Shin J, Park S, Kim R, Jeon B (2020) Patient-reported responses to medical treatment in primary dystonia. J Clin Neurosci 75:242\u2013244. https:\/\/doi.org\/10.1016\/j.jocn.2020.03.025","journal-title":"J Clin Neurosci"},{"key":"9172_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/jnnp.52.11.1312-a","volume":"52","author":"CG Ballard","year":"1989","unstructured":"Ballard CG (1989) Successful therapeutic intervention in a schizophrenic patient with blepharospasm. J Neurol Neurosurg Psychiatry 52:1312\u20131312. https:\/\/doi.org\/10.1136\/jnnp.52.11.1312-a","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9172_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/mdc3.13530","volume":"9","author":"G Defazio","year":"2022","unstructured":"Defazio G, Hallett M, Berardelli A, Perlmutter JS, Berman BD, Jankovic J, B\u00e4umer T, Comella C, Ercoli T, Ferrazzano G, Fox SH, Kim HJ, Moukheiber ES, Pirio Richardson S, Weissbach A, Gigante AF, Jinnah HA (2022) Measurement Properties of Clinical Scales Rating the Severity of Blepharospasm: A Multicenter Observational Study. Mov Disord Clin Pract 9:949\u2013955. https:\/\/doi.org\/10.1002\/mdc3.13530","journal-title":"Mov Disord Clin Pract"},{"key":"9172_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mds.22368","volume":"24","author":"J Jankovic","year":"2009","unstructured":"Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G (2009) Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord 24:407\u2013413. https:\/\/doi.org\/10.1002\/mds.22368","journal-title":"Mov Disord"},{"key":"9172_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/ana.410130406","volume":"13","author":"J Jankovic","year":"1983","unstructured":"Jankovic J, Ford J (1983) Blepharospasm and orofacial-cervical dystonia: Clinical and pharmacological findings in 100 patients. Ann Neurol 13:402\u2013411. https:\/\/doi.org\/10.1002\/ana.410130406","journal-title":"Ann Neurol"},{"key":"9172_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00005053-198202000-00010","volume":"170","author":"MC WHITE","year":"1982","unstructured":"WHITE MC, SILVERMAN JJ, HARBISON JW (1982) Psychosis Associated with Clonazepam Therapy for Blepharospasm. J Nerv Ment Dis 170:117\u2013119. https:\/\/doi.org\/10.1097\/00005053-198202000-00010","journal-title":"J Nerv Ment Dis"},{"key":"9172_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ana.410050418","volume":"5","author":"JR Merikangas","year":"1979","unstructured":"Merikangas JR, Reynolds CF (1979) Blepharospasm: Successful treatment with clonazepam. Ann Neurol 5:401\u2013402. https:\/\/doi.org\/10.1002\/ana.410050418","journal-title":"Ann Neurol"},{"key":"9172_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/BF02333790","volume":"10","author":"G Defazio","year":"1989","unstructured":"Defazio G, Lamberti P, Lepore V, Livrea P, Ferrari E (1989) Facial dystonia: clinical features, prognosis and pharmacology in 31 patients. Italian J Neurol Sci 10:553\u2013560. https:\/\/doi.org\/10.1007\/BF02333790","journal-title":"Italian J Neurol Sci"},{"key":"9172_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40734-016-0047-6","volume":"3","author":"P Termsarasab","year":"2016","unstructured":"Termsarasab P, Thammongkolchai T, Frucht SJ (2016) Medical treatment of dystonia. J Clin Mov Disord 3:19. https:\/\/doi.org\/10.1186\/s40734-016-0047-6","journal-title":"J Clin Mov Disord"},{"key":"9172_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s13311-013-0231-4","volume":"11","author":"MA Thenganatt","year":"2014","unstructured":"Thenganatt MA, Jankovic J (2014) Treatment of Dystonia. Neurotherapeutics 11:139\u2013152","journal-title":"Neurotherapeutics"},{"key":"9172_CR26","doi-asserted-by":"crossref","unstructured":"Green KE, Rastall D, Eggenberger E (2017) Treatment of blepharospasm\/hemifacial spasm. Curr Treat Options Neurol 19","DOI":"10.1007\/s11940-017-0475-0"},{"key":"9172_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1517\/14656560903426171","volume":"11","author":"LJ Cloud","year":"2010","unstructured":"Cloud LJ, Jinnah HA (2010) Treatment strategies for dystonia. Expert Opin Pharmacother 11:5\u201315","journal-title":"Expert Opin Pharmacother"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09172-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09172-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09172-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:06:55Z","timestamp":1783408015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09172-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["9172"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09172-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical concerns not applicable since no new investigation has been carried out.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"568"}}